Galectin Therapeutics Inc (NASDAQ:GALT)

4.22
Delayed Data
As of Feb 22
 +0.03 / +0.72%
Today’s Change
1.28
Today|||52-Week Range
6.74
+26.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-12.1M-15.8M-20.0M-21.4M
 
 
 
 
 
Depreciation12.0K10.0K7.0K7.0K
 
 
 
 
 
Total Other Cash Flow3.8M4.5M3.4M2.5M
 
 
 
 
 
Funds From Operations-8.3M-11.3M-16.6M-19.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-809.0K1.1M363.0K-2.5M
 
 
 
 
 
Net Cash Flow - Operating Activities-7.5M-12.4M-17.0M-16.4M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-400.0K0.000.00
 
 
Net Cash Flow Investing0.00-400.0K0.000.00
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale8.6M31.5M13.7M5.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing8.6M31.5M13.7M5.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash1.1M18.6M-3.3M-10.5M